CCR4 and stroke disorder: IMM-H004 is a compound screened from a system of C27 (CKLF1 agonist peptide) and CCR4, and our previous studies have shown that CKLF1 may play an important and detrimental role in the early phase of a stroke [28,29,30,46,47].